55KRC highlights Liver Cancer Awareness Month
UC experts discuss risk factors, new clinical trial efforts
October is Liver Cancer Awareness Month, highlighting the sixth most deadly and 13th most common cancer in the U.S.
Davendra Sohal, MD, associate professor of medicine, director of experimental therapeutics, clinic medical director in UC’s Division of Hematology/Oncology and a UC Health physician, said the main risk factor for liver cancer is cirrhosis of the liver. The main risk factors for cirrhosis include alcohol use, hepatitis B (which has a vaccine and is becoming less common) and hepatitis C, he said.
Sohal and Jordan Kharofa, MD, associate professor in the UC Department of Radiation Oncology and a UC Health physician, joined 55KRC's Angenette Levy on the Simply Medicine radio show and podcast to discuss Liver Cancer Awareness Month and a new clinical trial that is scheduled to open at UC early next year.
Listen to the Simply Medicine podcast.
Note: The segment with Drs. Sohal and Kharofa begins at around the 20:48 mark.
Featured photo at top of Dr. Sohal. Photo/UC Health
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.